JCO Precision Oncology Conversations

JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology" by Schwartz an

cfDNA Epigenetics for Toxicity Monitoring

JCO PO authors Dr. James Hadfield, Dr. Grace Yiqing Zhao, and Dr. Julia Elvin at AstraZeneca share insights into the JCO PO article, "Beyond Circulating Tumor DNA for Eff

JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors

In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, "Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Chi

ALK+ Squamous and Adenosquamous NSCLC

JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, "Clinicogenomic Characteristics and Treatment Outcomes of P

JCO PO Article Insights: Genomics of MTAP Loss and Co-Alteration Landscape

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive

Immune Checkpoint Blockade in dMMR/MSI-H Advanced UTUC

JCO PO authors Dr. Matthew Campbell and Dr. Mohammad Moussa at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, Texas, share ins

JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Fa

Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions

JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, "CRESTONE: A Phase II Study of the Efficacy and Safety of t

JCO PO Article Insights: Circulating Cancer Genome Atlas Study 5-year Outcomes

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DN

JCO PO Article Insights: Analytical Validation of Tumor-Informed ctDNA Assays for MRD

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DN

Oncotype DX Breast Recurrence Score® Results from Paired CNB & SE Specimens

In this JCO Precision Oncology Article Insights episode, host Dr. Carolyn Lineen summaries the article, "Concordance of Oncotype DX Breast Recurrence Score Assay Results

ctDNA in Metastatic Invasive Lobular Carcinoma

JCO PO author Dr. Foldi at UPMC Hillman Cancer Center and University of Pittsburgh School of Medicine shares insights into the JCO PO article, "Personalized Circulating T

JCO PO Article Insights: Circulating Tumor DNA in Germ Cell Tumors

In this JCO Precision Oncology Article Insights episode, host Dr. Jiasen He summaries the article, "Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Bioma

FGFR2b Prevalence in Advanced GC: FORTITUDE-101 Prescreening

JCO PO author Dr. Wainberg at UCLA shares insights into the JCO PO article, "Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening f

Palbociclib in Tumors with CDKN2A Loss or Mutation

In this JCO Precision Oncology Article Insights episode, host Dr. Harold Nathan Tan summarizes "Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CD

FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer

JCO PO author Dr. Shilpa Gupta at Cleveland Clinic Children's Hospital shares insights into her article, "Fibroblast Growth Factor Receptor 3 (FGFR3) Alteration Status an

JCO PO Article Insights: Genomic Risk Classifiers in Localized Prostate Cancer

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized"

DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas

Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, "Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homol

Somatic Mutations of Colorectal Cancer by Birth Cohort

In this episode of JCO PO Article Insights, host Dr. Jiasen He summarizes the article, "Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort" by Gilad, et al pu

Areas of Uncertainty in Pancreatic Cancer Surveillance

JCO PO author Dr. Bryson Katona at the University of Pennsylvania Perelman School of Medicine shares insights into his article, "Areas of Uncertainty in Pancreatic Cancer